ER+/HER2– breast cancer: Is first or second line CDK4/6 inhibitor therapy better?June 7, 2023Breast CancerPatient & Survivor Care
Ovarian cancer: Sequencing strategy identifies biomarker that could guide treatmentJune 6, 2023Gynecologic CancerPreventive CarePatient & Survivor Care
Metronomic chemotherapy performs well in second-line head and neck cancerJune 6, 2023Head & Neck/Thyroid CancersPatient & Survivor Care
Lower racial disparity in melanoma diagnoses in vets than U.S. men overall, study findsJune 5, 2023Melanoma
Antibody-drug conjugate changes standard of care for platinum-resistant ovarian cancerJune 5, 2023Gynecologic CancerImmunotherapyImmuno-oncologyPatient & Survivor Care
Oral drug for brain tumor could change treatment landscapeJune 4, 2023CNS/Brain CancerNeuro-oncologyPatient & Survivor Care
Up-front pembro plus chemo boost survival in cervical cancerJune 4, 2023Gynecologic CancerImmunotherapyImmuno-oncologyPatient & Survivor Care
Ribociclib forestalls recurrence also in early breast cancerJune 4, 2023Breast CancerMetastatic Breast CancerPatient & Survivor Care
‘Huge step forward’ in advanced ovarian cancerJune 4, 2023Gynecologic CancerImmunotherapyImmuno-oncologyPatient & Survivor Care
Omitting radiation in rectal cancer: ‘Less is more’June 4, 2023Gastrointestinal CancerPatient & Survivor CarePractice ManagementDiversity in MedicineGastroenterology
Phone support helps weight loss in patients with breast cancerJune 4, 2023Breast CancerPreventive CarePatient & Survivor Care
Medicaid expansion closing racial gap in GI cancer deathsJune 4, 2023Gastrointestinal CancerGastroenterologyDiversity in MedicinePatient & Survivor CarePractice Management
Cross-border U.S.-Mexican collaboration drives up ALL survivalJune 4, 2023Leukemia, Myelodysplasia, TransplantationPatient & Survivor CarePractice ManagementPediatricsDiversity in Medicine
